To improve the modernization level of the pharmaceutical industry, it is necessary to achieve breakthroughs in pharmaceutical equipment

[ Focus on Chemical Machinery and Equipment Network ] Data show that China’s fixed asset investment in 2020 is 5,18907 billion yuan, an increase of 2.
9% over the previous year, of which the pharmaceutical industry has brought strong support to the manufacturing industry.
Investment in the pharmaceutical manufacturing industry in 2020 The growth rate reached 28.
4%.
It is reported that during the "14th Five-Year Plan" period, my country's pharmaceutical industry will achieve seven goals.
One of them is to improve the modernization level of the industrial chain supply chain, make up for short boards and forged long boards, and solve a batch of stuck neck problems as soon as possible.
The key task also mentioned that it is necessary to promote key enterprises to achieve breakthroughs in drug design, production technology, high-end excipients, and pharmaceutical equipment .

As the "mother machine" of pharmaceutical production, pharmaceutical equipment plays an important role in the pharmaceutical manufacturing industry.
With the current growth in investment growth in the pharmaceutical manufacturing industry and favorable policies supporting the modernization of the industry, the pharmaceutical equipment industry is facing a situation where opportunities and challenges coexist.

 

Equipment demand growth The industry is ushering in a new round of prosperity
 

Data show that in 2020, the pharmaceutical special equipment manufacturing industry will achieve a total revenue of 19.
787 billion yuan, an increase of 14.
57% year-on-year, and a profit rate of 6.
44%.
This set of data means that in 2015, due to the decrease in equipment demand after the end of the GMP certification peak, the situation of the decline in industry revenue and profits has been changed, and the industry's recovery trend is obvious.  

　　In addition, with the growth of investment growth in the pharmaceutical manufacturing industry in 2020, pharmaceutical companies will continue to expand their demand for processes and equipment required for R&D and industrialization in the industrial chain.
In this context, the demand for pharmaceutical equipment is expected to usher in growth, and the industry believes that the industry is ushering in a new round of prosperity.

 

　　In fact, from the disclosed annual data of 2020 and the data of listed pharmaceutical machine companies in the first quarter of 2021, the industry's prosperity can also be explored.
Although the first quarter of 2020 was hit by the epidemic, after entering the second quarter, most companies have improved their performance and achieved certain growth throughout the year.
Some pharmaceutical companies such as Tung Fulong have doubled their net profit growth.
Entering 2021, many pharmaceutical machinery companies have indicated that they have sufficient orders and their performance is in the release period.  

　　Boosting the modernization of the pharmaceutical industry, there are still several major bottlenecks in the pharmaceutical industry that need to be broken
 

　　At present, my country's pharmaceutical equipment market has a wide variety of products, complete specifications, and large output, which can basically meet the production needs of domestic pharmaceutical companies.
However, to boost the modernization of the pharmaceutical industry, there are still several major bottlenecks that need to be broken through.

 

　　One is the technical bottleneck.
After years of development in the domestic pharmaceutical equipment industry, certain progress has been made in process technology, etc.
However, some pharmaceutical machinery products such as centrifuges are currently mainly dependent on imported parts and imported technologies, which are limited by people.
.
Therefore, to promote the modernization of the pharmaceutical industry, it is necessary to break the traditional technical bottleneck, innovate technology and process products, and realize the high-end development of the pharmaceutical machinery industry.  

　　Second, the level of innovation.
Due to the small scale and weak capital of most companies, there are obvious shortcomings in innovation, leading to the low-level repeated production of domestic pharmaceutical machinery, and the phenomenon of product homogeneity is serious, even among large pharmaceutical machinery companies.
This situation.
In the context of the continuous improvement of pharmaceutical product quality requirements and the continuous improvement of industry standards, it is necessary to improve the innovation level of pharmaceutical equipment.
For pharmaceutical machinery companies, as the market competition in the pharmaceutical machinery industry becomes more fierce, increasing investment in product innovation research and development and actively seeking a path to innovation and transformation is also a means to enhance corporate competitiveness.  

　　Concluding remarks
 

　　2021 is the first year of my country's "14th Five-Year Plan".
It is a general trend in various industries, including the pharmaceutical equipment industry, to promote industrial upgrading through technological innovation and to promote sustained and high-quality economic development.
Facing the new year, enterprises in the pharmaceutical equipment industry still need to make up for their shortcomings, overcome "difficult bones", realize the innovation and upgrade of domestic pharmaceutical equipment, promote the modernization of the pharmaceutical manufacturing industry, and promote the high-quality development of the industry.

 

　　Original title: To improve the modernization level of the pharmaceutical industry, it is necessary to achieve a breakthrough in the pharmaceutical equipment link